ARMOUR Residential REIT Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), ARMOUR Residential REIT Inc reported net income of $322.7M (+2341.8% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Interest Income (including $0, $0 and $973, respectively with BUCKLER) | $800.4M | $550.9M | $552.9M | $228.4M |
| Interest expense (including $(294,368), $(249,313) and $(245,846), respectively with BUCKLER) | ($642.1M) | ($524.1M) | ($525.8M) | ($120.8M) |
| Net Interest Income | $158.3M | $26.8M | $27.1M | $107.6M |
| Realized loss on sale of available for sale Agency Securities (reclassified from Other comprehensive loss) | $0 | $0 | ($7.5M) | ($7.5M) |
| Gain (Loss) on Agency Securities, trading, net | $514.8M | ($348.6M) | ($52.7M) | ($946.7M) |
| Gain (Loss) on U.S. Treasury Securities, net | ($10.0M) | $37.6M | ($43.1M) | — |
| Gain on derivatives, net | ($285.7M) | $323.5M | $51.7M | — |
| Total Other Income (Loss) | $219.1M | $12.5M | ($51.5M) | ($299.7M) |
| Management fees | $45.5M | $39.7M | $38.2M | $33.8M |
| Compensation | $3.6M | $4.7M | $4.9M | $5.5M |
| Other Operating | $12.3M | $15.8M | $7.0M | $6.4M |
| Total Expenses | $61.3M | $60.3M | $50.2M | $45.6M |
| Less management fees waived | ($6.6M) | ($6.6M) | ($6.6M) | ($7.8M) |
| Total Expenses after fees waived | $54.7M | $53.6M | $43.6M | $37.8M |
| Net Income (Loss) | $322.7M | ($14.4M) | ($67.9M) | ($229.9M) |
| Dividends on preferred stock | ($12.0M) | ($12.0M) | ($12.0M) | ($12.0M) |
| Net Income (Loss) available (related) to common stockholders | $310.6M | ($26.4M) | ($79.9M) | ($241.9M) |
| Reclassification adjustment for realized loss on sale of available for sale Agency Securities | $0 | $0 | $7.5M | $7.5M |
| Net unrealized gain on available for sale Agency Securities | $0 | $0 | $4.1M | ($130.1M) |
| Other Comprehensive income | $0 | $0 | $11.5M | — |
| Comprehensive Income (Loss) | $322.7M | ($14.4M) | ($56.4M) | ($348.4M) |
| Comprehensive Income (Loss) available (related) to common stockholders | $310.6M | ($26.4M) | ($68.4M) | ($360.4M) |
| Basic (in dollars per share) | $3.31 | -$0.51 | -$1.86 | -$2.05 |
| Diluted (in dollars per share) | $3.30 | -$0.51 | -$1.86 | -$2.05 |
| Dividends declared per common share (in dollars per share) | $2.88 | $2.88 | $5.00 | $1.20 |
| Basic (in shares) | 93.9M | 52.2M | 43.1M | 118.0M |
| Diluted (in shares) | 94.3M | 52.2M | 43.1M | 118.0M |
| Line item | Sep 30, 2026 · Q3 | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 |
|---|---|---|---|---|
| Interest Income | $274.3M | $263.9M | $249.2M | $210.2M |
| Interest expense (including $(93,128) and $(82,157) and $(260,192) and $(211,475), respectively with BUCKLER) | ($190.6M) | ($187.1M) | ($178.5M) | ($171.7M) |
| Net Interest Income | $83.7M | $76.8M | $70.7M | $38.5M |
| Gain (Loss) on Agency Securities, trading, net | ($1.2B) | ($42.6M) | ($182.6M) | $177.1M |
| Gain (Loss) on U.S. Treasury Securities, net | ($18.2M) | ($10.5M) | ($10.6M) | $6.2M |
| Gain (Loss) on derivatives, net | $792.4M | $108.2M | $83.0M | ($49.3M) |
| Total Other Income (Loss) | ($391.0M) | $55.2M | ($110.2M) | $134.0M |
| Management fees | $13.0M | $12.5M | $12.2M | $11.7M |
| Compensation | $1.5M | $1.2M | $953.0K | $926.0K |
| Other operating | $2.0M | $3.5M | $2.2M | $2.3M |
| Total Expenses | $16.5M | $17.2M | $15.3M | $14.9M |
| Less management fees waived | $0 | $0 | $0 | ($1.6M) |
| Total Expenses after fees waived | $16.5M | $17.2M | $15.3M | $13.3M |
| Net Income (Loss) | ($323.7M) | $114.8M | ($54.9M) | $159.3M |
| Dividends on preferred stock | ($3.3M) | ($3.3M) | ($3.2M) | ($3.0M) |
| Net Income (Loss) available (related) to common stockholders | ($327.1M) | $111.6M | ($58.0M) | $156.3M |
| Basic (in dollars per share) | -$2.26 | $0.86 | -$0.49 | $1.50 |
| Diluted (in dollars per share) | -$2.26 | $0.86 | -$0.49 | $1.49 |
| Dividends declared per common share (in dollars per share) | $0.72 | $0.72 | $0.72 | $0.72 |
| Basic (in shares) | 144.6M | 129.1M | 119.6M | 104.3M |
| Diluted (in shares) | 144.6M | 130.0M | 119.6M | 104.6M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $63.3M | $68.0M | $221.9M | — |
| Cash collateral posted to counterparties | $226.7M | $78.2M | $37.0M | $30.8M |
| Debt securities | $20.0B | $12.4B | $11.2B | $8.2B |
| Derivatives, at fair value | $611.5M | $908.1M | $877.4M | $984.5M |
| Accrued interest receivable | $86.2M | $52.9M | $47.1M | $28.8M |
| Prepaid and other | $1.7M | $1.4M | $1.3M | $2.1M |
| Total Assets | $21.0B | $13.5B | $12.3B | $9.4B |
| Repurchase agreements, net (including $8,426,540 and $4,895,003, respectively with BUCKLER) | $17.9B | $10.7B | $9.6B | $6.5B |
| Obligations to return securities received as collateral, at fair value | $0 | $493.4M | $350.3M | $502.7M |
| Cash collateral posted by counterparties | $419.4M | $833.9M | $860.1M | $963.6M |
| Payable for unsettled purchases | $302.1M | $103.5M | $171.5M | $353.4M |
| Derivatives, at fair value | $19.3M | $1.3M | $5.0M | $13.0M |
| Accrued interest payable - repurchase agreements (including $27,752 and $14,442, respectively with BUCKLER) | $59.3M | $32.1M | — | — |
| Accrued interest payable - U.S. Treasury Securities sold short | $0 | $3.8M | $5.0M | $3.4M |
| Accounts payable and other accrued expenses | $2.2M | $4.7M | $6.7M | $6.4M |
| Total Liabilities | $18.7B | $12.2B | $11.1B | $8.3B |
| Preferred stock, $0.001 par value, 50,000 shares authorized; 7.00% Series C Cumulative Preferred Stock; 7,048 shares and 6,847 shares issued and outstanding ($176,196 and $171,175 aggregate liquidation preference), respectively. | 7.0K | 7.0K | 7.0K | 7.0K |
| Common stock, $0.001 par value, 175,000 and 125,000 shares authorized; 111,915 shares and 62,412 shares issued and outstanding, respectively. | 112.0K | 62.0K | 49.0K | 163.0K |
| Additional paid-in capital | $5.4B | $4.6B | $4.3B | $3.9B |
| Cumulative distributions to stockholders | ($2.7B) | ($2.4B) | ($2.2B) | ($2.0B) |
| Accumulated net loss | ($518.2M) | ($840.9M) | ($826.5M) | ($758.5M) |
| Total Stockholders’ Equity | $2.3B | $1.4B | $1.3B | $1.1B |
| Total Liabilities and Stockholders’ Equity | $21.0B | $13.5B | $12.3B | $9.4B |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $99.7M | $83.7M | $66.5M | $44.2M |
| Cash collateral posted to counterparties | $34.2M | $351.8M | $147.7M | $264.3M |
| Debt securities | $20.5B | $21.2B | $20.5B | $18.1B |
| Receivable for unsettled sales (including pledged securities of $350,147 ($158,151 with BUCKLER) at September 30, 2026) | $411.8M | $344.4M | — | $296.5M |
| Derivatives, at fair value | $1.4B | $668.1M | $661.0M | $613.0M |
| Accrued interest receivable | $93.2M | $91.3M | $88.6M | $79.7M |
| Prepaid and other | $2.9M | $23.0M | $3.7M | $2.7M |
| Total Assets | $22.5B | $22.7B | $21.5B | $19.4B |
| Repurchase agreements, net (including $9,644,292 and $8,426,540, at September 30, 2026 and December 31, 2025, respectively with BUCKLER) | $19.4B | $19.4B | $18.5B | $16.6B |
| Cash collateral posted by counterparties | $649.5M | $330.7M | $401.2M | $453.6M |
| Payable for unsettled purchases | $0 | $241.1M | $148.2M | $72.9M |
| Derivatives, at fair value | $24.4M | $75.2M | $14.4M | $73.7M |
| Accrued interest payable- repurchase agreements (including $29,701 and $27,752, at September 30, 2026 and December 31, 2025, respectively with BUCKLER) | $58.3M | $72.3M | $83.4M | $64.0M |
| Accounts payable and other accrued expenses | $5.9M | $5.9M | $6.4M | $6.8M |
| Total Liabilities | $20.1B | $20.2B | $19.1B | $17.2B |
| Preferred stock, $0.001 par value, 50,000 shares authorized; 7.00% Series C Cumulative Preferred Stock; 7,676 shares and 7,048 shares issued and outstanding ($25.00 per share liquidation preference) at September 30, 2026 and December 31, 2025, respectively | $7000.00 | $7000.00 | $7000.00 | $7000.00 |
| Common stock, $0.001 par value, 250,000 and 175,000 shares authorized; 148,415 shares and 111,915 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively. | 148.0K | 136.0K | 124.0K | 112.0K |
| Additional paid-in capital | $6.1B | $5.9B | $5.7B | $5.4B |
| Cumulative distributions to stockholders | ($3.0B) | ($2.9B) | ($2.8B) | ($2.6B) |
| Accumulated net loss | ($781.9M) | ($458.2M) | ($573.0M) | ($729.9M) |
| Total Stockholders’ Equity | $2.4B | $2.6B | $2.3B | $2.1B |
| Total Liabilities and Stockholders’ Equity | $22.5B | $22.7B | $21.5B | $19.4B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net Income (Loss) | $322.7M | ($14.4M) | ($67.9M) | ($229.9M) |
| Net (accretion) amortization of premium (discount) on Agency Securities | $1.9M | ($345.0K) | $3.4M | $18.4M |
| Net amortization of U.S. Treasury Securities | $90.0K | $0 | $131.0K | ($1.9M) |
| Realized loss on sale of Agency Securities, available for sale | $0 | $0 | $7.5M | $7.5M |
| (Gain) Loss on Agency Securities, trading, net | ($514.8M) | $348.6M | $52.7M | $946.7M |
| (Gain) Loss on U.S. Treasury Securities, net | $10.0M | ($37.6M) | $43.1M | $152.3M |
| Stock based compensation | $2.1M | $3.2M | $3.2M | $3.7M |
| Increase in accrued interest receivable | ($32.9M) | ($5.9M) | ($18.5M) | ($17.7M) |
| (Increase) decrease in prepaid and other assets | ($287.0K) | ($159.0K) | $841.0K | ($1.0M) |
| Change in derivatives, at fair value | $314.5M | ($34.4M) | $99.1M | ($783.3M) |
| Increase in accrued interest payable- repurchase agreements | $27.2M | $5.6M | — | — |
| (Decrease) increase in accrued interest payable- U.S. Treasury Securities sold short | ($3.8M) | ($1.2M) | $1.6M | $3.4M |
| (Decrease) increase in accounts payable and other accrued expenses | ($2.5M) | ($2.0M) | $315.0K | $3.7M |
| Net cash and cash equivalents and cash collateral posted to counterparties provided by operating activities | $124.2M | $261.5M | $132.8M | $124.1M |
| Purchases of Agency Securities (including $0, $0 and $57,039 with BUCKLER, respectively) | ($9.6B) | ($7.3B) | ($10.3B) | ($11.5B) |
| Purchases of U.S. Treasury Securities (including $454,164, $0 and $155,857 with BUCKLER, respectively) | ($1.7B) | ($869.3M) | ($1.5B) | ($4.8B) |
| Principal repayments of Agency Securities | $1.7B | $1.1B | $803.2M | $573.6M |
| Proceeds from sales of Agency Securities | $1.6B | $4.6B | $6.3B | $6.3B |
| Proceeds from sales of U.S. Treasury Securities (including $100,502, $0 and $154,875 with BUCKLER, respectively) | $603.5M | $1.1B | $1.3B | $5.4B |
| Disbursements on reverse repurchase agreements (including $(1,860,188), $(4,643,450) and $(2,774,490), respectively with BUCKLER) | ($2.3B) | ($5.8B) | ($2.8B) | ($2.0B) |
| Receipts from reverse repurchase agreements (including $2,307,250, $4,550,325 and $3,124,829, respectively with BUCKLER) | $2.8B | $5.7B | $3.1B | $1.3B |
| Increase (decrease) in cash collateral posted by counterparties | ($414.4M) | ($26.3M) | ($103.5M) | $792.5M |
| Proceeds from subordinated loan due to BUCKLER | $0 | $0 | $105.0M | — |
| Net cash and cash equivalents and cash collateral posted to counterparties used in investing activities | ($7.3B) | ($1.7B) | ($3.0B) | ($3.9B) |
| Issuance of Series C Preferred stock, net of expenses | $4.1M | — | $0 | $0 |
| Issuance of common stock, net of expenses | $874.1M | $265.7M | $450.1M | $475.5M |
| Proceeds from repurchase agreements (including $89,783,916, $59,055,222 and $69,806,936, respectively with BUCKLER) | $157.0B | $105.4B | $119.7B | $80.1B |
| Principal repayments on repurchase agreements (including $(86,699,441), $(58,734,577) and $(68,737,266), respectively with BUCKLER) | ($150.3B) | ($104.2B) | ($116.9B) | ($76.9B) |
| Series C Preferred stock dividends paid | ($12.0M) | ($12.0M) | ($12.0M) | ($12.0M) |
| Common stock dividends paid | ($271.4M) | ($150.9M) | ($216.2M) | ($142.4M) |
| Common stock repurchased, net | ($19.9M) | ($1.3M) | ($9.9M) | ($7.7M) |
| Net cash and cash equivalents and cash collateral posted to counterparties provided by financing activities | $7.3B | $1.3B | $3.0B | $3.5B |
| Net increase (decrease) in cash and cash equivalents and cash collateral posted to counterparties | $143.8M | ($112.7M) | $140.8M | — |
| Cash and cash equivalents and cash collateral posted to counterparties - beginning of year | $146.2M | $258.9M | $118.1M | $356.2M |
| Cash and cash equivalents and cash collateral posted to counterparties - end of year | $290.0M | $146.2M | $258.9M | — |
| Cash paid during the year for interest | $735.4M | $686.2M | $607.0M | $137.0M |
| Payable for unsettled purchases | ($302.1M) | ($103.5M) | ($171.5M) | ($353.4M) |
| Net unrealized gain (loss) on available for sale Agency Securities | $0 | $0 | $4.1M | ($130.1M) |
| Amounts receivable for issuance of preferred stock | $36.0K | — | — | — |
| Line item | Sep 30, 2026 · YTD | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD |
|---|---|---|---|---|
| Net Income (loss) | ($263.8M) | $60.0M | ($54.9M) | $111.0M |
| Net (accretion) amortization of premium on Agency Securities | $2.2M | $4.7M | $3.3M | ($1.2M) |
| Net (accretion) amortization of U.S. Treasury Securities | ($76.0K) | ($34.0K) | ($39.0K) | $132.0K |
| (Gain) Loss on Agency Securities, trading, net | $1.4B | $225.2M | $182.6M | ($401.9M) |
| Loss on U.S. Treasury Securities, net | $39.3M | $21.1M | $10.6M | $9.6M |
| Stock based compensation | $2.3M | $1.3M | $559.0K | $1.6M |
| Increase in accrued interest receivable | ($7.7M) | ($5.3M) | ($2.8M) | ($26.9M) |
| Increase in prepaid and other assets | ($1.2M) | ($1.3M) | ($2.0M) | ($1.3M) |
| Change in derivatives, at fair value | ($743.6M) | ($647.0K) | ($54.3M) | $367.4M |
| Increase (decrease) in accrued interest payable- repurchase agreements | ($976.0K) | $13.0M | $24.2M | $31.9M |
| Decrease in accrued interest payable- U.S. Treasury Securities sold short | $0 | $0 | $0 | ($3.8M) |
| Increase in accounts payable and other accrued expenses | $3.7M | $3.7M | $4.2M | $2.1M |
| Net cash and cash equivalents and cash collateral posted to counterparties provided by operating activities | $420.7M | $321.7M | $111.6M | $88.6M |
| Purchases of Agency Securities | ($6.5B) | ($4.7B) | ($2.0B) | ($7.7B) |
| Purchases of U.S. Treasury Securities (includes $50,049 and $203,422 with BUCKLER, respectively) | ($501.7M) | ($501.7M) | ($501.7M) | ($1.1B) |
| Principal repayments of Agency Securities | $2.0B | $1.5B | $712.1M | $1.0B |
| Proceeds from sales of Agency Securities | $1.8B | $1.4B | $891.1M | $1.3B |
| Proceeds from sales of U.S. Treasury Securities (includes $49,000 and $100,502 with BUCKLER, respectively) | $586.6M | $491.4M | $99.7M | $351.6M |
| Disbursements on reverse repurchase agreements (includes $0 and $(1,860,188) with BUCKLER, respectively) | $0 | $0 | $0 | ($2.3B) |
| Receipts from reverse repurchase agreements (includes $0 and $2,307,250 with BUCKLER, respectively) | $0 | $0 | $0 | $2.8B |
| Decrease in cash collateral posted by counterparties | $230.1M | ($88.7M) | ($18.2M) | ($380.2M) |
| Net cash and cash equivalents and cash collateral posted to counterparties used in investing activities | ($2.4B) | ($1.9B) | ($839.6M) | ($5.9B) |
| Issuance of Series C Preferred stock, net of expenses | $13.0M | $10.5M | $6.4M | $279.0K |
| Issuance of common stock, net of expenses | $639.8M | $414.2M | $215.4M | $874.2M |
| Proceeds from repurchase agreements (including $60,497,426 and $64,158,045, respectively with BUCKLER) | $124.2B | $78.2B | $38.1B | $106.4B |
| Principal repayments on repurchase agreements (including $(59,279,674) and $(62,334,995), respectively with BUCKLER) | ($122.8B) | ($76.7B) | ($37.5B) | ($101.1B) |
| Series C Preferred stock dividends paid | ($9.8M) | ($6.4M) | ($3.2M) | ($9.0M) |
| Common stock dividends paid | ($284.8M) | ($179.4M) | ($86.3M) | ($190.7M) |
| Common stock repurchased | ($7.2M) | ($2.0M) | ($2.0M) | ($19.9M) |
| Net cash and cash equivalents and cash collateral posted to counterparties provided by financing activities | $1.8B | $1.7B | $652.3M | $6.0B |
| Net increase (decrease) in cash and cash equivalents and cash collateral posted to counterparties | ($156.1M) | $145.5M | ($75.8M) | $162.3M |
| Cash and cash equivalents and cash collateral posted to counterparties - beginning of period | $290.0M | $290.0M | $290.0M | $146.2M |
| Cash and cash equivalents and cash collateral posted to counterparties - end of period | $133.9M | $435.5M | $214.2M | $308.5M |
| Cash paid during the period for interest | $759.1M | $485.2M | $199.5M | $507.5M |
| Receivable for unsettled sales | $411.8M | $344.4M | — | $296.5M |
| Payable for unsettled purchases | $0 | ($241.1M) | ($148.2M) | ($72.9M) |
ARMOUR Residential REIT Inc score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.